QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meldrum, B. S. Search for Related Content PubMed PubMed Citation Articles by Meldrum, B. S.

---

Supplement

Glutamate as a Neurotransmitter in the Brain: Review of Physiology and Pathology¹

Department of Clinical Neurosciences, Institute of Psychiatry, London, SE5 8AF, UK

Glutamate is the principal excitatory neurotransmitter in brain. Our knowledge of the glutamatergic synapse has advanced enormously in the last 10 years, primarily through application of molecular biological techniques to the study of glutamate receptors and transporters. There are three families of ionotropic receptors with intrinsic cation permeable channels [N-methyl-D-aspartate (NMDA), -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and kainate]. There are three groups of metabotropic, G protein–coupled glutamate receptors (mGluR) that modify neuronal and glial excitability through G protein subunits acting on membrane ion channels and second messengers such as diacylglycerol and cAMP. There are also two glial glutamate transporters and three neuronal transporters in the brain. Glutamate is the most abundant amino acid in the diet. There is no evidence for brain damage in humans resulting from dietary glutamate. A kainate analog, domoate, is sometimes ingested accidentally in blue mussels; this potent toxin causes limbic seizures, which can lead to hippocampal and related pathology and amnesia. Endogenous glutamate, by activating NMDA, AMPA or mGluR1 receptors, may contribute to the brain damage occurring acutely after status epilepticus, cerebral ischemia or traumatic brain injury. It may also contribute to chronic neurodegeneration in such disorders as amyotrophic lateral sclerosis and Huntington’s chorea. In animal models of cerebral ischemia and traumatic brain injury, NMDA and AMPA receptor antagonists protect against acute brain damage and delayed behavioral deficits. Such compounds are undergoing testing in humans, but therapeutic efficacy has yet to be established. Other clinical conditions that may respond to drugs acting on glutamatergic transmission include epilepsy, amnesia, anxiety, hyperalgesia and psychosis.

KEY WORDS: • glutamate • excitotoxicity • domoate • neuroprotection • cerebral ischemia

This article has been cited by other articles:

				Y. Morishima, T. Miyakawa, T. Furuyashiki, Y. Tanaka, H. Mizuma, and S. Nakanishi Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice PNAS, March 15, 2005; 102(11): 4170 - 4175. [Abstract] [Full Text] [PDF]

				T. J. WORST and K. E. VRANA ALCOHOL AND GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM Alcohol Alcohol., January 1, 2005; 40(1): 63 - 75. [Abstract] [Full Text] [PDF]

				C. Caruso, M. C. Bottino, M. Pampillo, D. Pisera, G. Jaita, B. Duvilanski, A. Seilicovich, and M. Lasaga Glutamate Induces Apoptosis in Anterior Pituitary Cells through Group II Metabotropic Glutamate Receptor Activation Endocrinology, October 1, 2004; 145(10): 4677 - 4684. [Abstract] [Full Text] [PDF]

				H.-X. Chen and S. N. Roper Tonic Activity of Metabotropic Glutamate Receptors Is Involved in Developmental Modification of Short-Term Plasticity in the Neocortex J Neurophysiol, August 1, 2004; 92(2): 838 - 844. [Abstract] [Full Text] [PDF]

				H.-Y. Wu, K. Tomizawa, Y. Oda, F.-Y. Wei, Y.-F. Lu, M. Matsushita, S.-T. Li, A. Moriwaki, and H. Matsui Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration J. Biol. Chem., February 6, 2004; 279(6): 4929 - 4940. [Abstract] [Full Text] [PDF]

				P. Carratu, M. Pourcyrous, A. Fedinec, C. W. Leffler, and H. Parfenova Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1148 - H1157. [Abstract] [Full Text] [PDF]

				C. W. Leffler, L. Balabanova, A. L. Fedinec, C. M. Waters, and H. Parfenova Mechanism of glutamate stimulation of CO production in cerebral microvessels Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H74 - H80. [Abstract] [Full Text] [PDF]

				Z.-z. Su, M. Leszczyniecka, D.-c. Kang, D. Sarkar, W. Chao, D. J. Volsky, and P. B. Fisher Insights into glutamate transport regulation in human astrocytes: Cloning of the promoter for excitatory amino acid transporter 2 (EAAT2) PNAS, February 18, 2003; 100(4): 1955 - 1960. [Abstract] [Full Text] [PDF]